Longitudinal trends of systemic lupus erythematous hospitalizations in the United States: a two-decade population-based study.
Healthcare disparities
Hospitalization
Longitudinal trends
Systemic lupus erythematosus
Journal
Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
17
05
2022
accepted:
19
10
2022
revised:
14
10
2022
pubmed:
27
10
2022
medline:
22
2
2023
entrez:
26
10
2022
Statut:
ppublish
Résumé
Longitudinal data are limited on systemic lupus erythematosus (SLE) hospitalizations. We aim to study longitudinal trends of SLE hospitalizations in the last 2 decades in the United States (U.S). Data were obtained from the National Inpatient Sample database (NIS). We performed a 21-year longitudinal trend analysis of NIS 1998-2018. We searched for hospitalizations for adult patients with a "principal" diagnosis of SLE (SLE flare group) and those with "any" diagnosis of SLE (all SLE hospitalization group) using ICD codes. All non-SLE hospitalizations for adult patients were used as the control. Multivariable logistic and linear regression were used appropriately to calculate adjusted p-trend for the outcomes of interest. Incidence of SLE flare hospitalization reduced from 4.1 to 3.2 per 100,000 U.S persons from 1998 to 2018 (adjusted p-trend < 0.0001). The proportion of all hospitalized patients with SLE admitted principally for SLE reduced from 11.3% in 1998 to 5.7% in 2018 (adjusted p-tend < 0.0001). The proportion of hospitalized blacks in the SLE flare and all SLE hospitalization groups increased from 37.7% and 26.9% in 1998 to 44.7% and 30.7% in 2018 respectively (adjusted p-trend < 0.0001). The proportion of hospitalized Hispanics and Asians disproportionally increased in SLE flare hospitalizations compared to the control group. The incidence of hospitalization for SLE flare has reduced in the last 2 decades in the U.S. The proportion of hospitalized patients with SLE admitted principally for SLE has reduced significantly over time. However, the burden of SLE hospitalizations among ethnic minorities has increased over time. Key Points • The incidence of hospitalization for SLE flare has reduced in the last 2 decades in the U.S. • The proportion of hospitalized patients with SLE admitted principally for SLE has reduced significantly over time. • The burden of SLE hospitalizations among ethnic minorities such as blacks has increased over time.
Sections du résumé
BACKGROUND
BACKGROUND
Longitudinal data are limited on systemic lupus erythematosus (SLE) hospitalizations. We aim to study longitudinal trends of SLE hospitalizations in the last 2 decades in the United States (U.S).
METHODS
METHODS
Data were obtained from the National Inpatient Sample database (NIS). We performed a 21-year longitudinal trend analysis of NIS 1998-2018. We searched for hospitalizations for adult patients with a "principal" diagnosis of SLE (SLE flare group) and those with "any" diagnosis of SLE (all SLE hospitalization group) using ICD codes. All non-SLE hospitalizations for adult patients were used as the control. Multivariable logistic and linear regression were used appropriately to calculate adjusted p-trend for the outcomes of interest.
RESULTS
RESULTS
Incidence of SLE flare hospitalization reduced from 4.1 to 3.2 per 100,000 U.S persons from 1998 to 2018 (adjusted p-trend < 0.0001). The proportion of all hospitalized patients with SLE admitted principally for SLE reduced from 11.3% in 1998 to 5.7% in 2018 (adjusted p-tend < 0.0001). The proportion of hospitalized blacks in the SLE flare and all SLE hospitalization groups increased from 37.7% and 26.9% in 1998 to 44.7% and 30.7% in 2018 respectively (adjusted p-trend < 0.0001). The proportion of hospitalized Hispanics and Asians disproportionally increased in SLE flare hospitalizations compared to the control group.
CONCLUSION
CONCLUSIONS
The incidence of hospitalization for SLE flare has reduced in the last 2 decades in the U.S. The proportion of hospitalized patients with SLE admitted principally for SLE has reduced significantly over time. However, the burden of SLE hospitalizations among ethnic minorities has increased over time. Key Points • The incidence of hospitalization for SLE flare has reduced in the last 2 decades in the U.S. • The proportion of hospitalized patients with SLE admitted principally for SLE has reduced significantly over time. • The burden of SLE hospitalizations among ethnic minorities such as blacks has increased over time.
Identifiants
pubmed: 36287285
doi: 10.1007/s10067-022-06418-2
pii: 10.1007/s10067-022-06418-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
695-701Informations de copyright
© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).
Références
Anastasiou C, Trupin L, Glidden DV, Li J, Gianfrancesco M, Shiboski S, Schmajuk G, Yazdany J (2021) Mortality among hospitalized individuals with systemic lupus erythematosus in the US between 2006 and 2016. Arthritis Care Res 73(10):1444–1450. https://doi.org/10.1002/acr.24356
doi: 10.1002/acr.24356
HCUP databases. https://www.hcup-us.ahrq.gov . Assessed 14 October 2022
HCUP method series. https://www.hcup-us.ahrq.gov/reports/methods/TrendReport2005_1.pdf . Assessed 14 October 2022
United States Census Bureu. https://www.census.gov/data.html . Assessed 14 October 2022
Medical expenditure panel survey-based factor for hospital care. https://www.meps.ahrq.gov/mepsweb/ . Assessed 14 October 2022
Lupus | CDC. https://www.cdc.gov/lupus/index.htm . Assessed 14 October 2022
Li S, Gong T, Peng Y, Nieman KM, Gilbertson DT (2020) Prevalence and incidence of systemic lupus erythematosus and associated outcomes in the 2009–2016 US Medicare population. Lupus 29(1):15–26. https://doi.org/10.1177/0961203319888691
doi: 10.1177/0961203319888691
pubmed: 31726936
Barber M, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, Svenungsson E, Peterson J, Clarke AE, Ramsey-Goldman R (2021) Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 17(9):515–532. https://doi.org/10.1038/s41584-021-00668-1
doi: 10.1038/s41584-021-00668-1
pubmed: 34345022
pmcid: 8982275
Alarcón GS, Calvo-Alén J, McGwin G Jr, Uribe AG, Toloza SM, Roseman JM, Fernández M, Fessler BJ, Vilá LM, Ahn C, Tan FK, Reveille JD, LUMINA Study Group (2006) Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis 65(9):1168–1174. https://doi.org/10.1136/ard.200X.046896
doi: 10.1136/ard.200X.046896
pubmed: 16905579
pmcid: 1798273
González LA, Toloza SM, McGwin G Jr, Alarcón GS (2013) Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes. Lupus 22(12):1214–1224. https://doi.org/10.1177/0961203313502571
doi: 10.1177/0961203313502571
pubmed: 24097993
Maidhof W, Hilas O (2012) Lupus: an overview of the disease and management options. P T: Peer-Revi J Form Manag 37(4):240–249
Hannah J, Galloway J, Kaul A (2019) Changing hospitalization trends for systemic lupus erythematosus and rheumatoid arthritis in England. Lupus 28(7):906–913. https://doi.org/10.1177/0961203319853357
doi: 10.1177/0961203319853357
pubmed: 31159650
Piga M, Casula L, Perra D, Sanna S, Floris A, Antonelli A, Cauli A, Mathieu A (2016) Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001–2012. Lupus 25(1):28–37. https://doi.org/10.1177/0961203315596597
doi: 10.1177/0961203315596597
pubmed: 26199283
Menard LC, Habte S, Gonsiorek W, Lee D, Banas D, Holloway DA, Manjarrez-Orduno N, Cunningham M, Stetsko D, Casano F, Kansal S, Davis PM, Carman J, Zhang CK, Abidi F, Furie R, Nadler SG, Suchard SJ (2016) B cells from African American lupus patients exhibit an activated phenotype. JCI insight 1(9):e87310. https://doi.org/10.1172/jci.insight.87310
doi: 10.1172/jci.insight.87310
pubmed: 27699274
pmcid: 5033941
Dubey AK, Handu SS, Dubey S, Sharma P, Sharma KK, Ahmed QM (2011) Belimumab: first targeted biological treatment for systemic lupus erythematosus. J Pharmacol Pharmacother 2(4):317–319. https://doi.org/10.4103/0976-500X.85930
doi: 10.4103/0976-500X.85930
pubmed: 22025872
pmcid: 3198539
Hasan B, Fike A, Hasni S (2022) Health disparities in systemic lupus erythematosus-a narrative review. Clin Rheumatol 41(11):3299–3311. https://doi.org/10.1007/s10067-022-06268-y
doi: 10.1007/s10067-022-06268-y
pubmed: 35907971
pmcid: 9340727